Wenzel Spine Announces Leadership Changes

Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive surgical and diagnostic solutions for the treatment of spinal disorders, today announced that its Board of Directors has appointed Dr. Warren Neely as Chairman of the Board and William E. Wilson, President and Chief Executive Officer.

On March 7th, 2022, the unexpected passing of Wenzel Spine’s former President and CEO, Chad G. Neely, left many in the Wenzel Spine community stunned. Dr. Philip Sanger, Managing Partner of TEXO Ventures, said, “We are all going to miss Chad and the presence that he had with company employees, partners, and investors. We are fortunate that Dr. Warren Neely has graciously accepted the position of Chairman of the Board for Wenzel Spine. Dr. Neely is an experienced neurosurgeon who was an early proponent of the VariLift® System and has been actively involved in Wenzel Spine’s development.”

In addition, Wenzel Spine’s Board has appointed William E. (Bill) Wilson as President and Chief Executive Officer of Wenzel Spine. As a founding member of Wenzel Spine, Bill has built his career as an operations management and organizational leader, responsible for the development of the operations, finance, client relations, marketing, strategic partnerships, and medical education teams at Wenzel Spine. Bill’s experience and expertise have enabled him to expertly manage the continuously expanding team and product portfolio. Bill is focused on ensuring that the company’s growth is always centered around Wenzel’s surgeon partners and bringing value to their patients. With Bill’s background in software design and development, Bill can bring a unique perspective to the newest diagnostic solution offering at Wenzel Spine.

TEXO Ventures, Redmont Capital and iNetworks are excited about Bill Wilson assuming his new role as CEO of Wenzel Spine. Bill has been the COO of Wenzel Spine for 13 years and has the experience, knowledge, and vision to take the company forward in a successful manner. “I join our Board of Directors to proudly endorse Bill Wilson as our new CEO, he is the right leader for Wenzel Spine,” said Dr. Warren Neely, Wenzel Spine’s Chairman of the Board. “We are fortunate that Bill and Chad have worked so closely together over the past 13 years. Wenzel Spine is a very strong company, and we plan to continue moving forward in the direction that Chad, Bill, and our Board have always envisioned.”

Commenting on his appointment as CEO, Bill Wilson remarked, “This is a bittersweet transition for us all at Wenzel Spine. I am honored by the request and support of the Board to lead Wenzel Spine into its next chapter of growth and development. Wenzel has some truly innovative products and diagnostic automation technologies in the pipeline to help surgeons and their patients. For Wenzel Spine, our amazing team, and our partners, I am excited about our future.”

Bill holds Bachelor’s degree in Physiology and Computer Science and a Master’s in Computer Science from Michigan State University and his MBA from the University of Texas at Austin.

 

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.